Healthcare Companies and Catholic Hospitals: When Investing Conflicts with Care

Catholic healthcare systems own a lot of stock. Ascension, CommonSpirit Health, Trinity Health, and the other major Catholic hospital networks manage investment portfolios worth tens of billions of dollars combined. Those portfolios back pension obligations, capital reserves, and operating cash for organizations that provide about one in six hospital beds in the United States.

The portfolios also create ongoing tensions. Catholic hospitals exist to provide care consistent with Catholic moral teaching, which means they have to buy medical supplies from manufacturers and treat patients with therapies that sometimes conflict with their moral positions. When the healthcare system that treats your family members is also investing in the companies whose products it provides care with, interesting ethical questions arise.

Let's look at how this works in practice.

The scale of Catholic healthcare

The Catholic healthcare footprint in the United States is significant. As of 2024, the main Catholic health systems include:

CommonSpirit Health, formed by the 2019 merger of Dignity Health and Catholic Health Initiatives. Approximately 145 hospitals across 24 states.

Ascension, based in St. Louis, operating around 130 hospitals across 19 states.

Trinity Health, based in Michigan, with about 90 hospitals across 25 states.

Providence, based on the West Coast, operating about 50 hospitals primarily in Alaska, California, Oregon, Washington, Montana, Texas, and New Mexico.

Bon Secours Mercy Health, with about 50 hospitals primarily in the Midwest and Mid-Atlantic.

SSM Health, with about 25 hospitals across several states.

Catholic Health East, Catholic Health Services of Long Island, and various regional Catholic hospital networks.

Collectively, Catholic hospitals treat millions of patients annually and employ hundreds of thousands of healthcare workers. They're significant institutional investors as well, with pension funds and operational reserves that require professional management.

The investment portfolio challenge

A Catholic hospital system has to invest pension assets and operating reserves. Those investments are subject to Catholic moral teaching, which creates the same screening challenges that individual Catholic investors face, but with institutional complexity added.

The primary issues:

Pharmaceutical companies. The big pharma names (Johnson & Johnson, Pfizer, Merck, etc.) fail Catholic screening for reasons discussed in other articles in this series. But Catholic hospitals purchase drugs from these same companies to treat their patients. Is it consistent to refuse to invest in a company whose products you rely on daily for patient care?

Medical device manufacturers. Some medical devices are used for procedures that Catholic teaching prohibits (sterilization, certain reproductive interventions, etc.). Investments in device manufacturers may overlap with device purchases.

Health insurance companies. Insurers cover services that include things Catholic hospitals won't provide, which creates potential misalignment between investment decisions and care practices.

Research companies. Companies developing new therapies may use methods Catholic teaching opposes (embryonic stem cells, certain trial designs). Investment in research companies requires careful screening.

These aren't theoretical concerns. Catholic hospital investment committees actively work through these questions, with varying results and ongoing debate about the right approach.

The moral framework

Catholic moral theology provides tools for thinking about these tensions, though it doesn't provide mechanical answers.

The principle of cooperation with evil (Catechism paragraph 2487) distinguishes between formal cooperation (intending the evil act, always forbidden) and material cooperation (facilitating without intending, sometimes permitted). Catholic hospitals materially cooperate with pharmaceutical companies when they purchase drugs, and this cooperation is generally considered morally permissible because the alternative (not providing medication) would harm patients.

But is owning stock the same kind of material cooperation as purchasing drugs? The moral analysis is different. Purchasing is instrumental; you're using the drugs for patient care. Ownership is different; you're benefiting financially from the company's success, which includes success of its problematic product lines.

Most Catholic moral theologians conclude that stock ownership is a different category of cooperation than purchase for immediate use. You can licitly buy a drug to treat a patient without licitly owning stock in the company that makes it. The two decisions have different moral characters.

Applied to Catholic healthcare systems, this means the moral analysis for investment decisions can be stricter than the analysis for purchasing decisions. A hospital might need to buy Johnson & Johnson products to care for patients while its investment committee excludes Johnson & Johnson stock from the pension portfolio. This isn't inconsistent; it reflects the different moral characters of the two kinds of engagement with the company.

The Ethical and Religious Directives

Catholic hospitals operate under the Ethical and Religious Directives for Catholic Health Care Services (ERDs), a document issued by the USCCB that provides specific moral guidance for Catholic healthcare. The ERDs were most recently updated in 2018 and continue to be updated periodically.

The ERDs address:

Care for the sick and dying, including end-of-life care and the use of extraordinary measures
Reproductive issues, including the prohibition of direct abortion, direct sterilization, and contraception
Stewardship of resources, including how Catholic hospitals manage their operations financially
Cooperation with non-Catholic partners, including how Catholic hospitals can work with other providers whose practices may differ

Part Six of the ERDs specifically addresses cooperation with non-Catholic entities, which includes the investment context. The directives generally require Catholic institutions to avoid scandal (actions that might lead others to believe the institution condones immoral practices) and material cooperation with intrinsically evil acts.

The directives don't specifically address portfolio investment practices, but Catholic healthcare institutions have generally interpreted them to require investment screening consistent with the overall Catholic moral framework. This creates alignment between care practices and investment practices, even if the two have different moral analyses.

The supply chain dimension

Beyond investment portfolios, Catholic healthcare systems also have to think about supply chains. Medical supplies come from manufacturers whose other products and practices may raise concerns. Laboratory services use research methods that vary in their alignment with Catholic teaching. Pharmaceuticals are produced by companies with complex moral profiles.

Catholic hospital supply chains are rarely perfectly clean. Practical considerations often trump strict moral alignment because the alternative (refusing to purchase necessary supplies) would harm patients.

The moral analysis here relies on the principle of double effect and proportionate reason. A Catholic hospital can use supplies from morally questionable sources when:

The primary purpose is legitimate (patient care)
The cooperation with the problematic aspects is remote and unintended
The alternative (not providing care) would cause greater harm
The hospital actively seeks alternatives and supports better options where possible

This doesn't mean Catholic hospitals should be indifferent to supply chain issues. The ERDs and broader Catholic social teaching encourage active engagement with suppliers on ethical practices, support for alternative suppliers with better profiles, and transparency about supply chain decisions.

The tension with patient care

The most uncomfortable question for Catholic healthcare investors is whether their screening decisions actually affect patient care. If Catholic hospitals refuse to invest in major pharmaceutical companies, are they implicitly critiquing the drugs they use to treat patients? If they engage with companies on pricing and access, does that affect their ability to purchase supplies?

In practice, investment decisions and purchasing decisions are largely separate. A hospital can exclude a company from its investment portfolio while continuing to purchase its products. The investment decision is about financial benefit and moral cooperation; the purchase decision is about operational necessity and patient care.

But there are real tensions. Catholic hospitals that actively engage with pharmaceutical companies on drug pricing, for example, may find that their use is reduced when they're not also shareholders. Some Catholic healthcare investors have argued that owning stock in a company is a prerequisite for effective engagement, which would suggest including rather than excluding companies you want to influence.

The counterargument: if a company's core business model is inconsistent with Catholic moral teaching, you can't engage your way out of that fundamental issue. Shareholder pressure can change specific practices but can't change core business models. In those cases, exclusion may be more honest than engagement.

Different Catholic healthcare systems reach different conclusions about this tension. The result is that you can't identify a single "Catholic healthcare investment approach"; there are multiple faithful approaches within the broader Catholic healthcare community.

The pension obligation

Catholic healthcare systems have significant pension obligations to retired employees. These obligations have to be met regardless of investment philosophy, which creates practical pressures on investment decisions.

If Catholic screening reduces portfolio returns by even a small percentage over long periods, the impact on pension obligations is significant. A 0.5 percent annual drag on a $10 billion portfolio compounds to hundreds of millions of dollars over 20 years, which is real money that affects actual retirees.

This creates a fiduciary tension for Catholic healthcare investment committees. On one hand, they want to maintain moral consistency with Catholic teaching. On the other hand, they have fiduciary duties to pension beneficiaries that require prudent financial management.

The usual resolution: accept some modest tracking error as the cost of moral integrity, but don't pursue maximally strict screening if it would create material harm to pension obligations. This is a judgment-based approach that reasonable people can apply differently.

What retail investors can learn

Individual Catholic investors don't face the same institutional complexities as Catholic healthcare systems, but the principles translate:

You can purchase products from companies whose stock you don't own. Just because you decline to invest in a pharmaceutical company doesn't mean you can't take its medications when needed. The moral analyses for purchasing and investing are different.

Supply chains are complicated. Just as Catholic hospitals can't create perfectly clean supply chains, you can't create a perfectly clean consumer life. Practical compromise is sometimes necessary.

Engagement and exclusion both have legitimate roles. Sometimes engaging a company is more effective than excluding it. Sometimes exclusion is more honest. The choice depends on the specific situation and your prudential judgment.

Institutional structures create their own moral dimensions. How investment committees are structured, how they make decisions, and who they're accountable to all matter. Similar dynamics apply to your own investment decisions: how you think, who you consult, and how you evaluate choices all affect outcomes.

Fiduciary duty is real. Whether you're managing a $10 billion pension or your own $100,000 retirement account, you have obligations to future needs that require prudent management. Moral considerations don't eliminate financial considerations; they shape how you balance them.

The deeper integration

The Catholic healthcare investment challenge demonstrates a broader truth about Catholic social teaching on economics: it can't be reduced to mechanical rules because real life is more complex than any rule can capture. You can follow every rule and still fail at the underlying purpose. You can break the letter of various rules and still be acting with integrity.

This is why the USCCB guidelines and related documents emphasize prudential judgment, proportionate reason, and integration of moral principles rather than simple compliance checklists. Catholic social teaching assumes that faithful Catholics will engage with complex realities and make decisions that require wisdom, not just rule-following.

For Catholic healthcare systems, this means that investment decisions are part of a larger moral practice that includes patient care, employee relations, community engagement, and institutional witness. The investment portfolio is one expression of the institution's Catholic identity, not the only or even the most important one.

For retail Catholic investors, the same principle applies. Your portfolio is part of your broader Christian life, connected to your giving, your consumption, your work, your relationships, and your prayer. Getting the portfolio exactly right matters less than making it part of a consistent effort to live faithfully in all these areas simultaneously.

The Catechism paragraph 2443 states: "God blesses those who come to the aid of the poor and rebukes those who turn away from them." Catholic healthcare systems live out this teaching through patient care, especially care for those who can't pay. Their investment decisions matter but don't stand alone; they're part of a larger pattern of institutional witness.

For individual Catholic investors, your investment decisions similarly take their meaning from the larger pattern of your life. The USCCB guidelines give you the framework; your own faithful living puts it into practice. Neither alone is enough; both together can actually reflect Catholic social teaching in something like the integrated way the Church envisions.

Catholic healthcare navigates these tensions every day. The result isn't perfection, but it is faithful effort. That's the right model for retail Catholic investors too.